Headlines

Pfizer's first acute migraine treatment recommended by NICE

The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).

Phesi and Krystelis partner to improve diversity in trials and 'save sponsors millions' in costs

A partnership has been formed between Phesi and Krsytelis, born out of a need to address the lack of diversity in clinical trials.

Paid for and content provided by DHL Supply Chain

Control Towers in clinical trials: Harnessing logistics best practice to address pain points in the clinical trials market

There are many logistical obstacles faced by pharmaceutical companies. A Control Tower can provide quality controls built into processes from the outset.

CymaBay launches study into drug for liver scarring in patients with compensated cirrhosis

A study to evaluate the effect of seladelparm, a small molecule treatment by CymaBay Therapeutics, Inc. on patients with cirrhosis was announced this month (September 21).

Hires and retires: key appointments in pharma

BioPharma Reporter and Outsourcing Pharma is keeping you in the know with our most recent round-up of important appointments in the pharma industry - including Veranova, Matica Bio and Aldevron.

Paid for and in partnership with Lonza Small Molecules

Reducing the complexity of drug development through integrated services

Biotech companies face risks in drug development. Partnering with a CDMO that provides an integrated offering can reduce the potential for delays and greater expenses.

Novartis' ruxolitinab to treat rare blood cancer recommended for approval by NICE

Patients with a rare and incurable blood cancer, associated with an overproduction of blood cells, will soon have access to a small molecule Novartis treatment.

Global Industry News

Hot Topics

Spotlight

Women in Science: ScaleReady’s Jenny Stjernberg and her fervent passion for cell and gene therapies

TISSIUM CIO's Interest in science piqued by a childhood year in Mozambique

Astellas to pump $352 million into manufacturing facility in Ireland

Interview: Andrew MacGarvey COO of Phastar on opportunities for big analytical data

A deep dive with WuXi AppTec into HPAPIs: Risks, regulations, and revolutionary applications

Exciting line-up and speakers for the 7th IPF Annual Summit in Boston next month

FORE Biotherapeutics closes $75M financing to accelerate development of plixorafenib

Women in Science: Thermo Fisher’s Amy Butler: 'we are living in the golden age of biology'

Watch Yseop showcase Copilot 'the world's most secure automation solution'

Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation

Products

Webinars

On-demand webinars

ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization Recipharm AB

Featured Suppliers

All

Headlines

Pfizer's first acute migraine treatment recommended by NICE

Phesi and Krystelis partner to improve diversity in trials and 'save sponsors millions' in costs

Control Towers in clinical trials: Harnessing logistics best practice to address pain points in the clinical trials market

CymaBay launches study into drug for liver scarring in patients with compensated cirrhosis

Hires and retires: key appointments in pharma

Reducing the complexity of drug development through integrated services

Novartis' ruxolitinab to treat rare blood cancer recommended for approval by NICE

Global Industry News

Digitalization, AI and automation fueling life sciences industry growth, finds CRB

'Anti-tangle’ molecule could aid search for new dementia treatments

Women in Science: ScaleReady’s Jenny Stjernberg and her fervent passion for cell and gene therapies

Hot Topics

Hutchmed cancer drug set to enter Japanese market through Takeda

Opportunity Pharma and OpenEye join forces to develop AI expert for drug discovery

New tool enables target discovery for new class of diseases not yet mechanically understood

Positive, rapid and sustained effects on MDD patients treated with Relmada anti-depressant

Mural Health raises $8 million in seed funding to grow platform modernizing clinical trials

Merck KGgA collaborates with Exscientia plc in deal worth up to $674M

Spotlight

Follow us

Most popular News

Products

Webinars

Featured Suppliers

Outsourcing-Pharma

Resources